John M. Reno

1.0k total citations
15 papers, 833 citations indexed

About

John M. Reno is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, John M. Reno has authored 15 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Infectious Diseases. Recurrent topics in John M. Reno's work include Radiopharmaceutical Chemistry and Applications (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and DNA and Nucleic Acid Chemistry (3 papers). John M. Reno is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and DNA and Nucleic Acid Chemistry (3 papers). John M. Reno collaborates with scholars based in United States, Netherlands and Ireland. John M. Reno's co-authors include John A. Boezi, Lucy F. Lee, A. F. Isbell, Paul L. Weiden, Hazel B. Breitz, Paul L. Beaumier, Donald B. Axworthy, Scott S. Graves, Fu Su and S. Kasina and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Neuroscience.

In The Last Decade

John M. Reno

15 papers receiving 750 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John M. Reno United States 13 267 265 220 162 101 15 833
J L Winkelhake United States 15 234 0.9× 331 1.2× 115 0.5× 127 0.8× 340 3.4× 21 893
Wade Koba United States 15 91 0.3× 284 1.1× 276 1.3× 129 0.8× 80 0.8× 27 775
Fu‐Tong Liu United States 9 128 0.5× 430 1.6× 59 0.3× 63 0.4× 120 1.2× 10 721
James E. Stefano United States 15 277 1.0× 892 3.4× 78 0.4× 253 1.6× 81 0.8× 25 1.3k
Andrew A. Branca United States 13 224 0.8× 271 1.0× 83 0.4× 297 1.8× 546 5.4× 17 906
Sho Ishikawa Japan 17 169 0.6× 158 0.6× 152 0.7× 104 0.6× 571 5.7× 67 1.3k
Brad Harten United States 9 134 0.5× 264 1.0× 66 0.3× 94 0.6× 266 2.6× 10 895
L C Andersson Finland 18 143 0.5× 614 2.3× 69 0.3× 85 0.5× 273 2.7× 23 1.1k
Ian M. Zitron United States 14 276 1.0× 182 0.7× 134 0.6× 78 0.5× 455 4.5× 27 864
Jing An China 15 132 0.5× 371 1.4× 97 0.4× 67 0.4× 65 0.6× 53 872

Countries citing papers authored by John M. Reno

Since Specialization
Citations

This map shows the geographic impact of John M. Reno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Reno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Reno more than expected).

Fields of papers citing papers by John M. Reno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Reno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Reno. The network helps show where John M. Reno may publish in the future.

Co-authorship network of co-authors of John M. Reno

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Reno. A scholar is included among the top collaborators of John M. Reno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Reno. John M. Reno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Sergueev, Dmitri S., et al.. (2006). The chemistry and biology of KP-1461, a selective nucleoside mutagen for HIV therapy. Retrovirology. 3(S1). 1 indexed citations
2.
Breitz, Hazel B., Paul L. Weiden, Paul L. Beaumier, et al.. (2000). Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin.. PubMed. 41(1). 131–40. 124 indexed citations
3.
Gibson, Robin M., William P. Schiemann, Lisa Prichard, et al.. (2000). Phosphorylation of Human gp130 at Ser-782 Adjacent to the Di-leucine Internalization Motif. Journal of Biological Chemistry. 275(29). 22574–22582. 39 indexed citations
4.
Weiden, Paul L., Hazel B. Breitz, Oliver W. Press, et al.. (2000). Pretargeted Radioimmunotherapy (PRIT™) for Treatment of Non-Hodgkin's Lymphoma (NHL): Initial Phase I/II Study Results. Cancer Biotherapy and Radiopharmaceuticals. 15(1). 15–29. 110 indexed citations
5.
Hermann, Petra M., Ronald E. van Kesteren, Willem C. Wildering, et al.. (2000). Neurotrophic Actions of a Novel Molluscan Epidermal Growth Factor. Journal of Neuroscience. 20(17). 6355–6364. 41 indexed citations
6.
Graves, Scott S., Diane Stone, Don B. Axworthy, et al.. (1999). Molecular modeling and preclinical evaluation of the humanized NR-LU-13 antibody.. PubMed. 5(4). 899–908. 8 indexed citations
7.
Kasina, S., James Sanderson, Jeffrey N. Fitzner, et al.. (1998). Simplified Preformed Chelate Protein Radiolabeling with Technetium-99m Mercaptoacetamidoadipoylglycylglycine (N3S-Adipate). Bioconjugate Chemistry. 9(1). 108–117. 16 indexed citations
8.
Friedland, Robert P., Raj N. Kalaria, Marc S. Berridge, et al.. (1997). Neuroimaging of Vessel Amyloid in Alzheimer's Diseasea,b. Annals of the New York Academy of Sciences. 826(1). 242–247. 26 indexed citations
9.
Stratton, John R., Timothy A. Dewhurst, S. Kasina, et al.. (1995). Selective Uptake of Radiolabeled Annexin V on Acute Porcine Left Atrial Thrombi. Circulation. 92(10). 3113–3121. 79 indexed citations
10.
Friedland, Robert P., et al.. (1994). Development of an anti-Aβ monoclonal antibody for in vivo imaging of amyloid angiopathy in Alzheimer's disease. Molecular Neurobiology. 9(1-3). 107–113. 21 indexed citations
11.
Fritzberg, Alan R., et al.. (1994). Approaches to improved antibody- and peptide-mediated targeting for imaging and therapy of cancer. Journal of Controlled Release. 28(1-3). 167–173. 21 indexed citations
12.
Reno, John M., Lucy F. Lee, & John A. Boezi. (1978). Inhibition of Herpesvirus Replication and Herpesvirus-Induced Deoxyribonucleic Acid Polymerase by Phosphonoformate. Antimicrobial Agents and Chemotherapy. 13(2). 188–192. 79 indexed citations
13.
Sabourin, Carol L., John M. Reno, & John A. Boezi. (1978). Inhibition of eucaryotic DNA polymerases by phosphonoacetate and phosphonoformate. Archives of Biochemistry and Biophysics. 187(1). 96–101. 35 indexed citations
14.
Kern, Earl R., Lowell A. Glasgow, James C. Overall, John M. Reno, & John A. Boezi. (1978). Treatment of Experimental Herpesvirus Infections with Phosphonoformate and Some Comparisons with Phosphonoacetate. Antimicrobial Agents and Chemotherapy. 14(6). 817–823. 60 indexed citations
15.
Reno, John M., et al.. (1976). Mechanism of phosphonoacetate inhibition of herpesvirus-induced DNA polymerase. Biochemistry. 15(2). 426–430. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026